- Home
- PBYI vs VOR Comparison
PBYI vs VOR Comparison
Compare PBYI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- VOR
- Stock Information
- Founded
- PBYI 2010
- VOR 2015
- Country
- PBYI United States
- VOR United States
- Employees
- PBYI N/A
- VOR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- PBYI Health Care
- VOR Health Care
- Exchange
- PBYI Nasdaq
- VOR Nasdaq
- Market Cap
- PBYI 153.2M
- VOR 161.9M
- IPO Year
- PBYI N/A
- VOR 2021
- Fundamental
- Price
- PBYI $2.97
- VOR $1.33
- Analyst Decision
- PBYI Strong Buy
- VOR Strong Buy
- Analyst Count
- PBYI 1
- VOR 7
- Target Price
- PBYI $7.00
- VOR $11.36
- AVG Volume (30 Days)
- PBYI 821.3K
- VOR 1.1M
- Earning Date
- PBYI 02-27-2025
- VOR 11-07-2024
- Dividend Yield
- PBYI N/A
- VOR N/A
- EPS Growth
- PBYI 492.79
- VOR N/A
- EPS
- PBYI 0.47
- VOR N/A
- Revenue
- PBYI $243,569,000.00
- VOR N/A
- Revenue This Year
- PBYI N/A
- VOR N/A
- Revenue Next Year
- PBYI N/A
- VOR N/A
- P/E Ratio
- PBYI $6.38
- VOR N/A
- Revenue Growth
- PBYI 6.30
- VOR N/A
- 52 Week Low
- PBYI $2.23
- VOR $0.63
- 52 Week High
- PBYI $7.73
- VOR $2.56
- Technical
- Relative Strength Index (RSI)
- PBYI 45.95
- VOR 55.72
- Support Level
- PBYI $2.92
- VOR $1.29
- Resistance Level
- PBYI $4.06
- VOR $1.76
- Average True Range (ATR)
- PBYI 0.27
- VOR 0.21
- MACD
- PBYI -0.03
- VOR -0.01
- Stochastic Oscillator
- PBYI 4.39
- VOR 46.59
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.